Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › formoterol fumarate

formoterol fumarate

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of formoterol fumarate

6 trials tracked of formoterol fumarate: 6 in phase 3 or 4 and 5 with published results. The most-cited published study has 174 citations.

6Trials tracked
6Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 3 6
  1. Phase 3 Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination Completed · 174 cited
  2. Phase 3 Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Completed · 147 cited
  3. Phase 3 Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) Completed · 33 cited
  4. Phase 3 Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease Completed · 30 cited
  5. Phase 3 A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma Completed · 19 cited
  6. Phase 3 Study to Assess Efficacy and Safety of Aclidinium Bromide and Aclidinium Bromide/Formoterol Fumarate in Stabile COPD Patients Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
New propellant HFA-152a in BDP/FF/G pMDI shows similar efficacy to HFA-134a in asthma
Allergy & Immunology RCT
New propellant HFA-152a in BDP/FF/G pMDI shows similar efficacy to HFA-134a in asthma Trial shows HFA-152a and HFA-134a deliver equal lung function for asthma
This 12-week randomized controlled trial in 553 adults with moderate-to-severe controlled asthma found that BDP/FF/G delivered via HFA-152a …
A new trial found that two asthma inhaler propellants provided the same immediate lung function boost, with fewer side effects in one group.
May 1, 2026